# A Study of JNJ-75220795 in Japanese Participants

> **NCT05039710** · PHASE1 · TERMINATED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 9 (actual)

## Conditions studied

- Fatty Liver

## Interventions

- **DRUG:** JNJ-75220795
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05039710
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-08
- **Primary completion:** 2023-02-17
- **Final completion:** 2023-02-17
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Business Judgement
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05039710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05039710, "A Study of JNJ-75220795 in Japanese Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05039710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*